Evaluation of the Prognostic Value of T7 and T12 Slices on Mortality in Resuscitation Patients With ARDS Caused by SARS-COV2 Infection
Not yet recruiting
- Conditions
- Acute Respiratory Distress Syndrom (SARS-Cov 2)
- Registration Number
- NCT05594550
- Lead Sponsor
- Centre Hospitalier Universitaire Dijon
- Brief Summary
Sarcopenia is a risk factor for adverse outcome in critically ill patients. Sarcopenia might be estimated from muscle surface measure on tomodensitometry.
The purpose of the study is to identify if muscle surfaces measured on thoracic tomodensitometry are associated with mortality in patients with acute respiratory distress syndrome due to SARS-Cov-2.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
- patients hospitalized in intensive care for SARS-Cov-2 infection since january 2020
- Thoracic TDM within the 30 day preceding ICU admission and up to 24 hours after ICU admission
Exclusion Criteria
- Pregnancy
- Neuromuscular disease
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method measurement of muscle area at T7 level indexed in cm²/m². At hospital admission use of CT measurements to discriminate between the 2 groups (deceased versus alive)
- Secondary Outcome Measures
Name Time Method number of days in Intensive care unit within the 28 days Duration of mechanical ventilation within the 28 days Ventilator free days within the 28 days number of days in hospital within the 28 days